Loading...

Dong-Er Zhang

Title(s)Professor, Molecular Biology
SchoolHealth Sciences
Phone858-822-5372
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    USP18 in Cancer Development
    NIH/NCI R01CA232147Apr 1, 2019 - Mar 31, 2024
    Role: Principal Investigator
    CSF2 receptor mediated actions in t(8;21) leukemia
    NIH/NCI R01CA192924Feb 13, 2015 - Jan 31, 2020
    Role: Principal Investigator
    Synergestic roles of SRF2 and RUNX1 in blood cell development and pathology
    NIH/NIDDK R56DK098808Sep 16, 2013 - Aug 31, 2019
    Role: Principal Investigator
    Synergestic roles of SRF2 and RUNX1 in blood cell development and pathology
    NIH/NIDDK R01DK098808Sep 16, 2013 - Jun 30, 2018
    Role: Principal Investigator
    ISG15 and Protein ISGylation in Cancer
    NIH/NCI R01CA177305Mar 1, 2013 - Feb 29, 2024
    Role: Principal Investigator
    International RUNX Workshop
    NIH/NCI R13CA159538Jul 1, 2011 - Dec 31, 2011
    Role: Principal Investigator
    Cancer Researchers in Nanotechnology (CRIN)
    NIH/NCI T32CA153915Sep 3, 2010 - Apr 30, 2022
    Role: Principal Investigator
    UBP43 in Hematopoiesis
    NIH/NHLBI R01HL091549Sep 15, 2008 - Aug 31, 2014
    Role: Principal Investigator
    FASEB Conference-Hematological Malignancies
    NIH/NCI R13CA117424Jul 22, 2005 - Jun 30, 2010
    Role: Principal Investigator
    Mechanism of Interferon Response and Resistance in CML
    NIH/NCI R01CA102625Jul 16, 2004 - Jun 30, 2009
    Role: Principal Investigator
    Molecular Mechanism of Leukemogenesis Involving AML1-ETO
    NIH/NCI R01CA104509Dec 1, 2003 - Jun 30, 2020
    Role: Principal Investigator
    Role of Ubiquitin Like Protein ISG15 Conjugation
    NIH/NIGMS R01GM066955Dec 1, 2002 - Jun 30, 2012
    Role: Principal Investigator
    t(8;21) and SON in Blood Cell Proliferation and Differentiation
    NIH/NCI R01CA096735Jul 1, 2002 - Nov 30, 2014
    Role: Principal Investigator
    UBP43 in Hematopoiesis
    NIH/NCI R01CA079849Oct 25, 1999 - Mar 31, 2009
    Role: Principal Investigator
    INTERACTING FACTORS IN HEMATOPOIESIS AND LEUKEMIA
    NIH P01CA072009Sep 15, 1997 - Apr 30, 2008
    Role: Co-Investigator
    Comprehensive Biology: Exploiting the Yeast Genome
    NIH P41RR011823Sep 30, 1996 - Jun 30, 2016
    Role: Co-Investigator
    CD14 REGULATION BY MONOCYTE DIFFERENTIATION &CYTOKINES
    NIH/NCI R29CA059589Jul 1, 1994 - Jun 30, 2000
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Fan JB, Miyauchi S, Xu HZ, Liu D, Kim LJY, Burkart C, Cheng H, Arimoto KI, Yan M, Zhou Y, Gyorffy B, Knobeloch KP, Rich JN, Cang H, Fu XD, Zhang DE. Type I Interferon Regulates a Coordinated Gene Network to Enhance Cytotoxic T Cell-Mediated Tumor Killing. Cancer Discov. 2020 Mar; 10(3):382-393. PMID: 31974171.
      View in: PubMed
    2. Arimoto K, Burkart C, Yan M, Ran D, Weng S, Zhang DE. Plakophilin-2 promotes tumor development by enhancing ligand-dependent and -independent epidermal growth factor receptor dimerization and activation. Mol Cell Biol. 2014 Oct; 34(20):3843-54. PMID: 25113560.
      View in: PubMed